File image: A healthcare worker performs a trial run of COVID-19 vaccine delivery system in New Delhi, India. (Image: AP Photo/Altaf Qadri, File)
At least three states that administered Bharat Biotech’s Covaxin on January 16 have said that beneficiaries were reluctant to sign the consent form, according to a report by The Economic Times. This resulted in less than 50 percent strike rate – Bihar, Tamil Nadu and Telangana – on the first day of what is being called as the “world’s largest” COVID-19 vaccination exercise.
The issue was raised by the states in the coordination meeting chaired by Union Health Minister Dr. Harsh Vardhan later on January 16.
Follow our LIVE blog for the latest updates of the coronavirus pandemic
Tamil Nadu was able to administer just 99 Covaxin doses out of the planned 600 on the first day of the vaccination drive. The following day, it had administered 90 more doses till 2.00 pm, the report suggests.
All 11 states, which agreed to administer Covaxin doses, have dedicated six vaccination centres as part of the drive. All of these centres are restricted to government hospitals.
However, the news report suggests that beneficiaries in Rajasthan saw hesitation. The state administered 314 Covaxin doses out of the planned 600. No adverse event was reported from the vaccine in the state. Rajasthan’s National Health Mission director Naresh Thakral told the newspaper that translating the consent form to Hindi may have helped.
COVID-19 Vaccine Tracker: All you need to know about manufacturing and pricing
This comes at a time when some experts and politicians have raised concerns regarding the efficacy of Covaxin, which is currently under phase-3 clinical trials.
Bharat Biotech's COVID-19 vaccine Covaxin, developed in collaboration with the Indian Council of Medical Research (ICMR), was granted restricted emergency use approval under the clinical trial mode. This means that people who receive the doses will have to sign a three-page informed consent form, and will also be monitored for any serious side effects. This was the first such approval given to a vaccine in India.
Read: What is informed consent form for Covaxin, what information is sought and other questions answered
A total of 2.24 lakh beneficiaries were inoculated with the COVID-19 vaccine so far in India. Of these, a total of 447 adverse events were reported following immunisation (AEFI), the Union Health Ministry said on day two of the nationwide vaccination drive on January 17.
Besides Covaxin, the Drugs Controller General of India (DCGI) had also approved Covishield produced by the Serum Institute of India (SII).Click here for Moneycontrol’s full coverage of the coronavirus pandemic